Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Glenmark Pharmaceuticals has announced the upcoming launch of zanubrutinib in India following approval by the Drugs Controller General of India (DCGI).
Zanubrutinib will be marketed in India under the brand name BRUKINSA.
At 10.46 am, Glenmark Pharmaceuticals was trading at Rs. 1,604.75, down by 0.93%, with a volume of 6950 lakh shares on the BSE.
Partnership will see Ericsson manage Airtel’s pan-India network through its state-of-the-art NOC
9 Jun 2025, 11:38AML&T bags order in the range of Rs. 1,000-2,500 cr from JSW Energy for a heavy civil infrastructure project in Maharashta
9 Jun 2025, 10:20AMRailTel bags order worth Rs. 274.4 cr from Motor Vehicles Department, Maharashtra
05-06-2025 12:26:11Indian stock markets continue to trade higher led by buying in index heavyweights.
05-06-2025 11:36:30Almost 20 lakh shares changed hands in a pre-open block deal.
04-06-2025 10:42:11Budget 2024 Analysis
